Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions
- PMID: 12401330
- DOI: 10.1016/s0306-4522(02)00379-2
Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions
Abstract
Cocaine blocks uptake by neuronal plasma membrane transporters for dopamine, serotonin and norepinephrine, producing subjective effects in humans that are both euphoric/rewarding and also fearful, jittery and aversive. Mice with gene knockouts of each of these transporters display cocaine reward, manifest by cocaine place preferences that are at least as great as wildtype values. Norepinephrine and serotonin receptor knockouts even display enhanced cocaine reward. One explanation for these observations could be that cocaine produces aversive or anhedonic effects by serotonin or norepinephrine receptor blockade in wildtype mice that are removed in serotonin or norepinephrine receptor knockouts, increasing net cocaine reward. Adaptations to removing one transporter could also change the rewarding valence of blocking the remaining transporters. To test these ideas, drugs that block serotonin transporter (fluoxetine), norepinephrine transporter (nisoxetine) or all three transporters (cocaine) were examined in single- or multiple-transporter knockout mice. Fluoxetine and nisoxetine acquire rewarding properties in several knockouts that are not observed in wildtype mice. Adding serotonin transporter knockout to norepinephrine transporter knockouts dramatically potentiates cocaine reward. These and previous data provide evidence that serotonin and norepinephrine transporter blockade can contribute to the net rewarding valence of cocaine. They identify neuroadaptations that may help to explain the retention of cocaine reward by dopamine and serotonin transporter knockout mice. They are consistent with emerging hypotheses that actions at the three primary brain molecular targets for cocaine each provide distinct contributions to cocaine reward and cocaine aversion in wildtype mice, and that this balance changes in mice that develop without dopamine, norepinephrine or serotonin transporters.
Similar articles
-
Molecular mechanisms underlying the rewarding effects of cocaine.Ann N Y Acad Sci. 2004 Oct;1025:47-56. doi: 10.1196/annals.1316.006. Ann N Y Acad Sci. 2004. PMID: 15542699 Review.
-
Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5300-5. doi: 10.1073/pnas.091039298. Proc Natl Acad Sci U S A. 2001. PMID: 11320258 Free PMC article.
-
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.J Neurosci. 2002 Jan 15;22(2):389-95. doi: 10.1523/JNEUROSCI.22-02-00389.2002. J Neurosci. 2002. PMID: 11784783 Free PMC article.
-
Cocaine, reward, movement and monoamine transporters.Mol Psychiatry. 2002;7(1):21-6. doi: 10.1038/sj.mp.4000964. Mol Psychiatry. 2002. PMID: 11803442 Review.
-
Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice.Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7699-704. doi: 10.1073/pnas.95.13.7699. Proc Natl Acad Sci U S A. 1998. PMID: 9636213 Free PMC article.
Cited by
-
Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms.Eur J Pharmacol. 2015 Oct 5;764:562-570. doi: 10.1016/j.ejphar.2015.07.044. Epub 2015 Jul 21. Eur J Pharmacol. 2015. PMID: 26209364 Free PMC article. Review.
-
Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction.Front Psychiatry. 2013 Sep 23;4:109. doi: 10.3389/fpsyt.2013.00109. Front Psychiatry. 2013. PMID: 24069004 Free PMC article. Review.
-
Behavior of knock-in mice with a cocaine-insensitive dopamine transporter after virogenetic restoration of cocaine sensitivity in the striatum.Neuropharmacology. 2014 Apr;79:626-33. doi: 10.1016/j.neuropharm.2013.12.023. Epub 2014 Jan 9. Neuropharmacology. 2014. PMID: 24412674 Free PMC article.
-
Implications of genome wide association studies for addiction: are our a priori assumptions all wrong?Pharmacol Ther. 2013 Dec;140(3):267-79. doi: 10.1016/j.pharmthera.2013.07.006. Epub 2013 Jul 18. Pharmacol Ther. 2013. PMID: 23872493 Free PMC article. Review.
-
Role of serotonin in cocaine effects in mice with reduced dopamine transporter function.Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):372-7. doi: 10.1073/pnas.0207805101. Epub 2003 Dec 22. Proc Natl Acad Sci U S A. 2004. PMID: 14691264 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases